Aura Biosciences (AURA) Capital Expenditures (2020 - 2026)
Aura Biosciences (AURA) reported Capital Expenditures of $20000.0 for Q1 2026, down 89.3% on a YoY basis from $187000.0 in Q1 2025, and down 88.64% quarter-over-quarter from $176000.0 in Q4 2025.
Aura Biosciences (AURA) Capital Expenditures (2020 - 2026) Analysis & Trends
Aura Biosciences has reported Capital Expenditures for 7 years, with the latest figure at $20000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 89.3% year-over-year to $20000.0; the trailing twelve-month figure through Mar 2026 stood at $280000.0 (up 180.0% YoY), and the FY2025 full-year result was $447000.0, up 1177.14% from the prior year.
- Capital Expenditures for Q1 2026 stood at $20000.0, down from $176000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $644000.0 in Q4 2023, with the low at -$919000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $81823.5 across 5 years, with a median of $122000.0 in 2024.
- The largest YoY upside for Capital Expenditures was 743.66% in 2022 against a maximum downside of 313.58% in 2022.
- Aura Biosciences' Capital Expenditures stood at -$556000.0 in 2022, then jumped by 215.83% to $644000.0 in 2023, then sank by 242.7% to -$919000.0 in 2024, then soared by 119.15% to $176000.0 in 2025, then slumped by 88.64% to $20000.0 in 2026.
- The last three Capital Expenditures figures came in at $20000.0 (Q1 2026), $176000.0 (Q4 2025), and $45000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -63,220.27 |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | 20,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | -919,000.00 |
| Dec 31, 2024 | -919,000.00 |
| Sep 30, 2024 | 341,000.00 |
| Sep 30, 2024 | 341,000.00 |
| Jun 30, 2024 | 491,000.00 |
| Jun 30, 2024 | 491,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Mar 31, 2024 | 122,000.00 |
| Dec 31, 2023 | 644,000.00 |
| Dec 31, 2023 | 644,000.00 |